Trinity Biotech
TRIB
20 hedge funds and large institutions have $5.67M invested in Trinity Biotech in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
5% more funds holding
Funds holding: 19 → 20 (+1)
0.14% less ownership
Funds ownership: 1.55% → 1.41% (-0.14%)
5% less capital invested
Capital invested by funds: $5.95M → $5.67M (-$283K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$30.9K |
| 2 |
VF
Virtu Financial
New York
|
+$27.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$27.5K |
| 4 |
IWA
Inspirion Wealth Advisors
Libertyville,
Illinois
|
+$19.4K |
| 5 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
+$3.94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonehill Capital Management
New York
|
-$507K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$85.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10.6K |
| 5 |
Renaissance Technologies
New York
|
-$3.69K |
TRIB Hedge Fund Activity: Q2 2024 in Review
20 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q2 2024, worth a combined $5.67M — down 4.8% from $5.95M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new TRIB positions and 5 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Hunter Associates Investment Management, adding an estimated $30.9K. The largest seller was Stonehill Capital Management, exiting entirely with an estimated $507K sold.
- 20 institutional investors held Trinity Biotech (TRIB) as of Q2 2024, up from 19 in Q1 2024.
- Funds reported $5.67M of Trinity Biotech stock for Q2 2024, down 4.8% quarter-over-quarter.
- 6 funds opened new Trinity Biotech positions in Q2 2024 and 5 closed out, a net change of +1 holder.
- The largest Trinity Biotech buyer in Q2 2024 was Hunter Associates Investment Management, an estimated $30.9K added.
- The largest Trinity Biotech seller in Q2 2024 was Stonehill Capital Management, an estimated $507K sold.
Based on aggregated 13F filings for Q2 2024.